Sign up


Match Document Document Title
US20120021440 METHODS FOR TESTING LIGAND BINDING TO G PROTEIN-COUPLED RECEPTORS  
The present invention relates to methods for testing for the binding of a ligand to a G Protein-Coupled Receptor. In particular, the methods of the invention are useful in high throughput screening...
US20110110918 ROLE OF (DE)ACETYLATION IN COUNTERACTING PROTEIN AGGREGATION  
The invention provides a method for influencing an activity of a heat shock protein which is a member of the Hsp40/DnaJ family, the method comprising acetylating or deacetylating said heat shock...
US20110223616 HuR-Associated Biomarkers  
The present invention relates to methods of identifying gene targets, including methods of using ribonucleoprotein (RNP) immunoprecipitation-microarrays to identify cancer gene targets, such as...
US20120288895 Compositions and Methods for Modulating Hemostasis Using Variant Forms of Activated Factor V  
Methods for the treatment of coagulation disorders using Factor V/Va variants are provided.
US20120183562 SECRETED FXYD PROTEINS EXPRESSED IN RESPONSE TO EPITHELIAL TISSUE DAMAGE, AND USES THEREFOR  
Secreted FXYD family proteins are expressed by intestinal mucosa and/or associated tissues to regulate cell production in intestinal crypts in response to tissue damage. Such tissue damage may...
US20110078821 HEAT RESISTANT PLANTS AND PLANT TISSUES AND METHODS AND MATERIALS FOR MAKING AND USING SAME  
The subject invention concerns materials and methods for providing plants or plant tissue with increased resistance to heat conditions and/or increased starch biosynthesis. Increased resistance of...
US20120117685 Isolated Novel Nucleic Acid and Protein Molecules from Soybeans and Methods of Using Thos Molecules  
This disclosure provides purified nucleic acids and polypeptides and various uses of these sequences such as transcript profiling. Also provided are transgenic plants, seeds, and plant cells...
US20110110859 Protein  
The present invention provides methods and compositions for screening, diagnosis and prognosis of colorectal cancer, for monitoring the effectiveness of colorectal cancer treatment, and for drug...
US20120289688 EXPRESSION SYSTEM  
Polynucleotides are provided herein.
US20110117072 HYPERACTIVE VARIANTS OF THE TRANSPOSASE PROTEIN OF THE TRANSPOSON SYSTEM SLEEPING BEAUTY  
The present invention refers to hyperactive variants of a transposase of the transposon system Sleeping Beauty (SB). The invention further refers to corresponding nucleic acids producing these...
US20110165168 CIDEA MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA  
An in vitro or in vivo method for screening for candidate compounds for the preventive or curative treatment of acne, of seborrhoeic dermatitis or of skin disorders associated with hyperseborrhoea,...
US20110207116 SPATIO-TEMPORAL CONTROL OF PROTEIN INTERACTIONS USING PHYTOCHROMES  
The invention provides methods, materials and systems of regulating association between proteins of interest using light. In an aspect, the invention takes advantage of the ability of phytochromes...
US20130029400 GENETIC ELEMENTS, PROTEINS, AND ASSOCIATED METHODS INCLUDING APPLICATION OF ADDIITNAL GENETIC INFORMATION TO GRAM (+) THERMOACIDOPHILES  
Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods for modulating or altering...
US20110275135 Genetic elements, proteins, and associated methods including application of additional genetic information to gram (+) thermoacidophiles  
Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods for modulating or altering...
US20130052685 PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS  
The invention concerns the prevention and treatment of complement-associated eye conditions, such as choroidal neovascularization (CNV) and age-related macular degeneration (AMD), by administration...
US20110112022 Factor VIII Muteins with Reduced Immonugenicity  
The invention relates to modified Factor VIII molecules with reduced N-linked glycosylation and reduced immunogenicity. The invention also relates to methods of using modified Factor VIII...
US20130164786 FUCOSYLATION-DEFICIENT CELLS  
An isolated nucleic acid encoding an FX protein having a serine at position 79, a lysine at position 90, a leucine at position 136, an arginine at position 211, a serine at position 289, and a...
US20100304436 Fucosylation-Deficient Cells  
An isolated nucleic acid encoding an FX protein having a serine at position 79, a lysine at position 90, a leucine at position 136, an arginine at position 211, a serine at position 289, and a...
US20120029184 METHODS OF AND SYSTEMS FOR ISOLATING CAROTENOIDS AND OMEGA-3 RICH OIL PRODUCTS FROM ALGAE  
A method of isolating nutraceuticals products from algae is provided. A method of isolating carotenoids and omega-3 rich oil from algae includes dewatering substantially intact algal cells to make...
US20130326727 Modified Protein Body Tags and Production Methods Thereof  
The present invention belongs to genetic engineering technical field and discloses modified protein body tags, a system for evaluating the efficacy of the modified polypeptides, and methods for...
US20120329663 14-3-3 sigma as a Biomarker of Basal Cancer  
Methods and compositions for using 14-3-3sigma gene and protein as a highly sensitive and specific basal breast cancer biomarker, which when present, correlates with metastasis and poor outcome in...
US20130337444 NANO46 Genes and Methods to Predict Breast Cancer Outcome  
The present invention provides methods for classifying and for evaluating the prognosis of a subject having breast cancer are provided. The methods include prediction of breast cancer subtype using...
US20110318727 GENETIC MARKER FOR DETECTION OF HUMAN PAPILLOMAVIRUS  
The invention provides compositions and methods for the differential detection of high risk forms of HPV from a urine sample provided by a patient. Specifically, the invention provides primers and...
US20130143210 METHOD FOR THE PROGNOSIS OF OVARIAN CARCINOMA  
The invention relates to a method for determining prognosis of subjects with ovarian carcinoma using a biological sample comprising genomic tumor DNA isolated from the subject. According to the...
US20140073572 TARGETING COMPLEMENT FACTOR H FOR TREATMENT OF DISEASES  
The invention provides a CR2-FH molecule comprising a CR2 portion comprising CR2 protein or a fragment thereof and a FH portion comprising a factor H protein or a fragment thereof, and...
US20110015127 TARGETING COMPLEMENT FACTOR H FOR TREATMENT OF DISEASES  
The invention provides a CR2-FH molecule comprising a CR2 portion comprising CR2 protein or a fragment thereof and a FH portion comprising a factor H protein or a fragment thereof, and...
US20130202638 VACCINE AGAINST BETA-HERPESVIRUS INFECTION AND USE THEREOF  
The present invention is related to a beta-herpesvirus, wherein the beta-herpesvirus is spread-deficient.
US20130217751 POLYNUCLEOTIDES FOR REDUCING RESPIRATORY SYNCYTIAL VIRUS GENE EXPRESSION  
This invention pertains to polynucleotides, such as small interfering RNA (siRNA), useful for reducing the expression of respiratory syncytial virus (RSV) genes within a subject; and methods for...
US20110213009 ADFP MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA  
An in vitro or in vivo method for screening for candidate compounds for the preventive or curative treatment of acne, of seborrhoeic dermatitis or of skin disorders associated with hyperseborrhoea,...
US20120324600 CONSTITUTIVE SYNTHETIC PLANT PROMOTERS AND METHODS OF USE  
Control of transgene expression in planta is dependent upon genetic elements that affect both transcription and translation of mRNA transcripts. The disclosed invention describes the combination of...
US20110182902 Recombination Sequence (RS) Rearrangement Frequency as a Measure of Central B Cell Tolerance  
The invention relates to methods and materials for diagnosing an autoimmune disease such as SLE, Type 1 diabetes, and the like. More particularly, the invention relates to methods and materials for...
US20110275081 BIOMARKER FOR DIAGNOSIS OF CANINE CANCER  
The present invention is related to a biomarker for diagnosis of canine cancer, wherein the biomarker is KMO (kynureinie 3-monooxygenase) gene, and the canine cancers including CTVT (canine...
US20110071284 NOVEL B-TYPE GENE FROM OIL PALM  
The present invention relates generally to genetic sequences and their complementary forms capable of facilitating the modification of a phenotype of a plant. More particularly, the present...
US20130210645 PERSONALIZED TUMOR BIOMARKERS  
Clinical management of human cancer is dependent on the accurate monitoring of residual and recurrent tumors. We have developed a method, called personalized analysis of rearranged ends (PARE),...
US20130302821 Method For Evaluating Atherosclerotic Lesion, And Kit  
The present invention provides a method and a means for evaluating atherosclerotic lesions by identifying a protein (marker protein) group, the expression level of which varies according to the...
US20110010804 GENES THAT INCREASE PLANT OIL AND METHOD FOR USING THE SAME  
This invention is intended to be used to search for a transcription factor having novel functions of increasing the weight of an individual plant, increasing the weight of a given tissue per...
US20100311994 GENES THAT INCREASE PLANT OIL AND METHOD FOR USING THE SAME  
This invention is intended to be used to search for a transcription factor having novel functions of increasing the weight of an individual plant, increasing the weight of a given tissue per...
US20110268742 PCTP MODULATORS IN THE TREATMENT OF ACNE, OF SEBORRHOEIC DERMATITIS OR OF HYPERSEBORRHOEA  
An in vitro or in vivo method for screening for candidate compounds for the preventive or curative treatment of acne, of seborrhoeic dermatitis or of skin disorders associated with hyperseborrhoea,...
US20120278909 COMPOSITIONS AND METHODS FOR DETERMINING GENETIC POLYMORPHISMS IN THE TMEM216 GENE  
In alternative embodiments, the invention provides nucleic acid sequences that are genetic polymorphic variations of the human TMEM216 gene, and TMEM216 polypeptide encoded by these variant...
US20120096582 RICE TRANSGENIC EVENT 17053 AND METHODS OF USE THEREOF  
The present invention provides a transgenic rice event 17053 and plants, plant cells, seeds, plant parts, and commodity products derived from event 17053. The present invention also provides...
US20120066791 RICE TRANSGENIC EVENT 17314 AND METHODS OF USE THEREOF  
The present invention provides a transgenic rice event 17314 and plants, plant cells, seeds, plant parts, and commodity products derived from event 17314. The present invention also provides...
US20120046241 DOSE OF AVE5026 FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL IMPAIRMENT  
This invention relates to a dose of 10 mg of AVE5026 for the treatment of venous thromboembolism in patients with severe renal impairment.
US20130281549 BIOLOGIC BONDING AGENT  
A sterile biofilm could be engineered to isolate the glue-like substance while eliminating the adverse properties of the bacteria. The resulting sterile glue-like substance would be used to help...
US20130269060 Proteins Toxic To Hemipteran Insect Species  
The present invention discloses Hemipteran insect inhibitory proteins, methods of using such proteins, nucleotide sequences encoding such proteins, methods of detecting and isolating such proteins,...
US20110305727 RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME  
The present invention relates to immunogenic compositions comprising RSV F protein, methods for preparing compositions that contain RSV F protein ecto-domain polypeptides, and to certain engineered...
US20110173719 CONSTITUTIVE PROMOTER FROM OIL PALM TYPE 2  
The present invention relates generally to a gene promoter from an oil palm plant and to a genetically modified plant comprising same. The gene promoter of the present invention is useful in...
US20100331268 Nitrated Lipids and Methods of Making and Using Thereof  
Described herein are nitrated lipids and methods of making and using the nitrated lipids.
US20130045938 KINASE MODULATORS FOR THE TREATMENT OF CANCER  
A method of treating cancer in which a compound that inhibits the expression, production or release of IL-10 by immune cells is combined with a compound that stimulates the production of IL-12 when...
US20130344482 GENE FOR PREDICTING THE PROGNOSIS FOR EARLY-STAGE BREAST CANCER, AND A METHOD FOR PREDICTING THE PROGNOSIS FOR EARLY-STAGE BREAST CANCER BY USING THE SAME  
The present invention relates to a method for selecting a gene intended to predict the prognosis for a cancer, to the selected gene for predicting the prognosis of cancer and to a kit for...
US20110150771 CHIMERIC WEST NILE/DENGUE VIRUSES  
The disclosure provides chimeric West Nile/Dengue viruses comprising non-coding regions, non-structural proteins, and a C protein from a West Nile virus and prM and E proteins from a Dengue virus....